Biblio
In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis. Nat Genet. 2023.
Preleukemic single-cell landscapes reveal mutation-specific mechanisms and gene programs predictive of AML patient outcomes. Cell Genom. 2023;3(12):100426.
HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemia. Blood. 2022.
Transcriptional variability accelerates preleukemia by cell diversification and perturbation of protein synthesis. Sci Adv. 2022;8(31):eabn4886.
Intratumoral Heterogeneity: Tools to Understand and Exploit Clone Wars in AML. Cancer Cell. 2018;34(4):533-535.
. Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia. Ther Adv Hematol. 2015;6(3):103-119.
.